{"database": "openregs", "table": "dockets", "rows": [["FDA-2005-P-0194", "FDA", "Evaluation of the Adequacy of Warnings to Patient-Consumers that Psychosis Is a Possible Adverse effect of Keppra (levetiracetam) - CLOSED", "Nonrulemaking", "2021-09-01T01:01:17Z", "0b00006480440ea4"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2005-P-0194"], "units": {}, "query_ms": 8.849441073834896, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}